Joseph B. Bolen, Ph.D. from Millennium to Conference Chair Cancer Sessions at IBC's Drug Discovery & Development of Innovative Therapeutics ...(opment of Innovative TherapeuticsConfere...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Joseph B. Bolen, Ph.D. from Millennium to Conference Chair Cancer Sessions at IBC's Drug Discovery & Development of Innovative Therapeutics Conference
Date:6/30/2008
opment of Innovative Therapeutics Conference and Exhibition is an international event that covers topics across multiple therapeutic areas. The event includes over 15 presentations from more than 200 speakers, 150 exhibitors, 13 interactive round table discussions and 4 keynote presentations. For more information please visit http://www.drugdisc.com.
Complete details on this event can be found at http://www.drugdisc.com or to receive a press pass or arrange an interview with a speaker, email Keri Dostie at kdostie@ibcusa.com.
About IBC Life Sciences
IBC Life Sciences is the worldwide leader in scientific, technological
and business conferences and courses for the life science industry. To
develop its programs, IBC actively researches the advancements,
technologies and trends impacting and driving the race for new drugs and
therapies. No other organization can make claim to the breadth and quality
that IBC Life Sciences delivers in each event giving the company
recognition around the globe for quality, service and value. For more
information, visit: http://www.IBCLifeSciences.com.
Contact: Keri Dostie
IBC Life Sciences
508-614-1404
'/>"/>
| SOURCE IBC Life Sciences Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. Seahorse Bioscience Appoints Former Molecular Devices Executive Dr. Joseph D. Keegan to Board of Directors
2. Dr. Joseph L. Corriveau Appointed Director of Research and Technology
3. SGX Pharmaceuticals Appoints Joseph L. Turner to Board of Directors
4. Micromet, Inc. Elects Joseph P. Slattery to Board of Directors
5. J. Craig Venter Institute Names Robert Friedman, Ph.D., Deputy Director of West Coast Facility
6. Barry Ginsberg, M.D., Ph.D. Elected to Biodels Board of Directors
7. DermTech Names Herbert A. Fritsche, Ph.D., Chief of Clinical Chemistry at M.D. Anderson Cancer Center to Companys Scientific Advisory Board
8. Takedas Antibody Therapeutics Research Company, Takeda San Francisco, Inc. Appoints Mary Haak-Frendscho, Ph.D. as President and CSO
9. Lucy Shapiro, Ph.D., Elected to Gen-Probe Board of Directors
10. Adnavance Technologies Inc. Appoints Christian P. Valcke, Ph.D., to Its Scientific Advisory Board
11. Michael D. Taylor, Ph.D., Joins Cequent Pharmaceuticals Board of Directors
Post Your Comments:
(Date:11/24/2009)... The FBI recently approved the Promega P...icipating in or generating DNA records for the Nat... Madison, WI USA (PRWEB) -- The FBI recently appro...use by laboratories participating in, or generatin...NDIS). NDIS currently contains more than seven mil...
(Date:11/24/2009)...URE:HTL , TORONTO,Nov.24/PRNewswire-FirstCall...italInc.,aleadingproviderofadvancedlasersystemsand...cmarkets,todayreportedoperationalandfinancialresul...009Highlights,-Revenuewas$1.46millioncomparedwith...entcomparedwith66.1percentinQ3,2008,-Netlossreduce...
(Date:11/24/2009)...O,Nov.24,2009/PRNewswire-FirstCall/--ArenaPharmace...companyisscheduledtopresentatthePiperJaffray21stAn....EasternTime(8:30a.m.PacificTime)attheNewYorkPalac...ChiefExecutiveOfficer,isscheduledtoprovideanovervi...iscoveryprograms. ,, Aliveaudiowebcastofthepres...
(Date:11/24/2009)...taly,November24/PRNewswire/--HealthRoboticstodayan...hagroupofselected,investors.ThisrecentlyformedToro...ticsCanada,Inc.andwillmarket,install,andsupport,He...desthe,revolutionaryproductofferingsi.v.STATION(TM....willalsoprovideassistanceonan"asneeded,basis"toit...
Breaking Biology Technology:NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2[0] NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database [0] Hamilton Thorne announces third quarter results[0] Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference[0] Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada
...: SHP,NASDAQ: SHPGY ), the global specialty biop...ion agreement with GlaxoSmithKline plc (NYSE: GS...apsules CII with the aim of,improving recognition ...greement covers the United States and will more th...ales effort for VYVANSE by adding over 600 sales,r...
...eted product, a new vaccine against Japanese Encep... - Commercial product launch in the U.S. planned f...E: ICLL) today announced that the U.S. Food and Dr...vaccine for the prevention of Japanese Encephaliti...vaccine - the only such product currently manufact...
...nsulting US, a division of London-based Double Hel...ent of Ann Stuchiner to the position of Vice Presi... highly experienced strategic pricing, reimburseme...perience across the healthcare industry, which pro...n the pharmaceutical, biotechnology and medical de...
Other Biology Technology:Shire and GlaxoSmithKline Enter Agreement to Co-promote VYVANSE(R) (lisdexamfetamine dimesylate) CII for the Treatment of Adults With ADHD 2Shire and GlaxoSmithKline Enter Agreement to Co-promote VYVANSE(R) (lisdexamfetamine dimesylate) CII for the Treatment of Adults With ADHD 3Shire and GlaxoSmithKline Enter Agreement to Co-promote VYVANSE(R) (lisdexamfetamine dimesylate) CII for the Treatment of Adults With ADHD 4Shire and GlaxoSmithKline Enter Agreement to Co-promote VYVANSE(R) (lisdexamfetamine dimesylate) CII for the Treatment of Adults With ADHD 5Shire and GlaxoSmithKline Enter Agreement to Co-promote VYVANSE(R) (lisdexamfetamine dimesylate) CII for the Treatment of Adults With ADHD 6Intercell Announces FDA Approval of IXIARO(R), a Novel Vaccine to Prevent Japanese Encephalitis 2Intercell Announces FDA Approval of IXIARO(R), a Novel Vaccine to Prevent Japanese Encephalitis 3Intercell Announces FDA Approval of IXIARO(R), a Novel Vaccine to Prevent Japanese Encephalitis 4Double Helix Appoints Ann Stuchiner Vice President of US Consulting Division 2Shire and GlaxoSmithKline Enter Agreement to Co-promote VYVANSE(R) (lisdexamfetamine dimesylate) CII for the Treatment of Adults With ADHDIntercell Announces FDA Approval of IXIARO(R), a Novel Vaccine to Prevent Japanese EncephalitisDouble Helix Appoints Ann Stuchiner Vice President of US Consulting Division
(Date:11/24/2009)... NEW YORK (November 24, 2009) -- The Wildlife Con...evealing that the last remaining population of Sib... to the rising tide of poaching and habitat loss. ...rm Russian officials of what needs to be done to p...t cat. , The report was released by...
(Date:11/24/2009)... (November 24, 2009) New research on bacterial co...tems reveals predictable temporal patterns, sugges...s markers for monitoring climate change in the pol... Proceedings of the National Academy of Sciences ... the six rivers shifted synchronously over time, c...
(Date:11/23/2009)...C. The community-associated strain of the deadly ...nt to most common antibioticsposes a far greater h...ts way into hospitals, according to a study in the... , The new threat is easily picked up in fitnes...s increased the overall burden of MRSA within hosp...
Breaking Biology News(10 mins):Report shows dramatic decline in Siberian tigers 2Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2New study finds MRSA on the rise in hospital outpatients 2Nurses AFL CIO Unions to Host Michael Moore and Special Screening of New Film at AFL CIO Convention 56663 1Nurses AFL CIO Unions to Host Michael Moore and Special Screening of New Film at AFL CIO Convention 56663 2GENova appoints Director of Asian business development 56661 1GENova appoints Director of Asian business development 56661 2Vita Tech International Inc Donates One Ton of Vitamins To Polio Treatment Centers in Guinea West Africa 13950 1...ns School of Medicine and their colleagues have fo...ptor in addition to their own can acquire new colo... rapidly to new sensory information than anticipat...lso suggests that when the first ancestral primate...0 million years ago, it probably experienced immed...
...School of Medicine & Dentistry at The Universi...Edinburgh, have discovered a way to kill the cysti...se investigators, under the leadership of Dr. Migu...ogy, have had their research published in the May ...ted in Nature Reviews/Microbiology. , B. cenocepa...
...pment of new neurons in specific brain regions aff...n, new research shows. How these new neurons stor...how they can affect learning and memory in adults...., of the Salk Institute, found that experience enh...called the dentate gyrus, and that more of these n...
Other Biology News:Making mice with enhanced color vision 2Making mice with enhanced color vision 3Key found to kill cystic fibrosis superbug 2Experience affects new neuron survival in adult brain; study sheds light on learning, memory 2Mouse Anti-Simian Virus 5 Monoclonal Antibody, Unconjugated from AbD Serotec
Mouse Anti-Simian Virus 5 Monoclonal Antibody, FITC Conjugated from AbD Serotec
Mouse Anti-Human MBP aa67-74 Monoclonal Antibody, Unconjugated from AbD Serotec
... The DNAclear cDNA Purification Kit is designed to...nzymatic reactions such as cDNA synthesis and PCR....ng from 1 ng to 3 g can be efficiently purified an... three steps: 1) DNA is bound to the Microfilter C...
Biology Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |